In a recent trial, medical students who were trained for two hours or less in an ultrasound “volume sweep” imaging (VSI) protocol obtained diagnostic-quality imaging of palpable breast lesions.

CMS has released its highly anticipated tentative rule for governing the 2023 Medicare Physician Fee Schedule (MPFS). In turn, the American College of Radiology has posted a first-look summary focused on the schedule’s implications for medical imaging.  

GE previously indicated that the iodinated contrast shortage would resolve by the end of June.

The shortage of iodinated contrast media that has rattled U.S. radiology since early May didn’t come from nowhere.

The FDA is notifying patients and referrers of another breast-imaging service’s slide into noncompliance with regulatory standards for image quality.

The 40 evidence-based recommendations touch on everything from patient selection to study choice, radiation safety, clinical team dynamics, procedural techniques, study interpretations and more. 

A clinical trial pitting MRI against a burgeoning PET/CT technique has found the de facto defending champion better at revealing the presence of any grade of prostate cancer.

In the June 29 announcement, the ACR revealed CMS said the additional evidence provided to them was “insufficient” to support the reconsideration of their non-coverage decision.